The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study

Torben Frøstrup Hansen; René dePont Christensen; Rikke Fredslund Andersen; Karen-Lise Garm Spindler; Flemming Brandt Sørensen; Anders Johnsson; Anders Jakobsen

The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study

Torben Frøstrup Hansen, René dePont Christensen, Rikke Fredslund Andersen, Karen-Lise Garm Spindler, Flemming Brandt Sørensen, Anders Johnsson, Anders Jakobsen

Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review

Original language	English
Publication date	2012
Publication status	Published - 2012
Event	ASCO 2012 - Chicago, United States Duration: 1. Jun 2012 → 5. Jun 2012

Conference

Conference	ASCO 2012
Country/Territory	United States
City	Chicago
Period	01/06/2012 → 05/06/2012

Cite this

Hansen, T. F., Christensen, R. D., Fredslund Andersen, R., Spindler, K.-L. G., Sørensen, F. B., Johnsson, A., & Jakobsen, A. (2012). The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study. Poster session presented at ASCO 2012, Chicago, United States.

Hansen, Torben Frøstrup ; Christensen, René dePont ; Fredslund Andersen, Rikke et al. / The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study. Poster session presented at ASCO 2012, Chicago, United States.

@conference{9db24ab566b943989d20e4e5a3afb570,

title = "The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study",

author = "Hansen, {Torben Fr{\o}strup} and Christensen, {Ren{\'e} dePont} and {Fredslund Andersen}, Rikke and Spindler, {Karen-Lise Garm} and S{\o}rensen, {Flemming Brandt} and Anders Johnsson and Anders Jakobsen",

year = "2012",

language = "English",

note = "ASCO 2012 ; Conference date: 01-06-2012 Through 05-06-2012",

}

Hansen, TF, Christensen, RD, Fredslund Andersen, R, Spindler, K-LG, Sørensen, FB, Johnsson, A & Jakobsen, A 2012, 'The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study', ASCO 2012, Chicago, United States, 01/06/2012 - 05/06/2012.

The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study. / Hansen, Torben Frøstrup; Christensen, René dePont; Fredslund Andersen, Rikke et al.
2012. Poster session presented at ASCO 2012, Chicago, United States.

Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review

TY - CONF

T1 - The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study

AU - Hansen, Torben Frøstrup

AU - Christensen, René dePont

AU - Fredslund Andersen, Rikke

AU - Spindler, Karen-Lise Garm

AU - Sørensen, Flemming Brandt

AU - Johnsson, Anders

AU - Jakobsen, Anders

PY - 2012

Y1 - 2012

M3 - Poster

T2 - ASCO 2012

Y2 - 1 June 2012 through 5 June 2012

ER -

Hansen TF, Christensen RD, Fredslund Andersen R, Spindler KLG, Sørensen FB, Johnsson A et al.. The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study. 2012. Poster session presented at ASCO 2012, Chicago, United States.